291534-16-2

Basic information

• Product Name: tert-Butyl-2-methanesulfonyloxy-6-Phenylhex-4-ynylether
• Synonyms: tert-Butyl-2-methanesulfonyloxy-6-Phenylhex-4-ynylether
• CAS NO: 291534-16-2
• Molecular Weight: 324.441
• Mol File: 291534-16-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: tert-Butyl-2-methanesulfonyloxy-6-Phenylhex-4-ynylether(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl-2-methanesulfonyloxy-6-Phenylhex-4-ynylether(291534-16-2)
• EPA Substance Registry System: tert-Butyl-2-methanesulfonyloxy-6-Phenylhex-4-ynylether(291534-16-2)

Safety Data

• Hazardous Substances Data: 291534-16-2(Hazardous Substances Data)

Upstream product

• 7665-72-7 t-butyl glycidyl ether 
• 291534-15-1 1-tert-butoxy-6-phenyl-hex-4-yn-2-ol 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 291534-17-3 1-hydroxy-2-azido-6-Phenylhex-4-yn 
• 291534-19-5 1-Hydroxy-2-{[4'-methoxy-(1,1'-biphenyl)-4-yl]-sulfonyl}-amino-6-phenylhex-4-yn 
• 1026429-74-2 methanesulfonic acid 1-hydroxymethyl-5-phenyl-pent-3-ynyl ester 

Relevant articles and documents

Alkenyl- and alkynl-containing metalloprotease inhibitors

Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to the following Formula (I): where X, W, Z, A, G, R1, R2, R3, R4, R5, R5′and k have the meanings described in the specification. This invention also includes optical isomers, diastereomers and enantiomers of the formula above, and pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof Also described are pharmaceutical compositions comprising these compounds, and methods of treating or preventing metalloprotease-related maladies using the compounds or the pharmaceutical compositions.